Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation TCT India 2025

Intervention to Prevention

Presenter: Brajesh Mittal

July 26, 2025

Presentation AHA 2024

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

Presenter: Chisato Izumi

November 17, 2024

Presentation SCAD 2022

MINOCA: Causes and Investigation Algorithm

Presenter: Janet Wei

February 19, 2022

Presentation JIM 2018

Case: Immediately after PCI and BAV the patient was given aspirin 250 mg iv and Plavix 300 mg

Presenter: Ferdinando Varbella

February 23, 2018

Presentation TTT 2018

Prolonged DAPT should be Standard of Care Post PCI?

Presenter: Tan Huay Cheem

January 14, 2018

Presentation

Predictors of Long-term Major CV Events and Death in Patients With Unprotected Left Main CAD

July 20, 2017

Presentation

Risk of Adverse Cardiac and Bleeding Events Following Surgery in Patients With Stents

Presenter: Francesco Saia

December 07, 2015

Presentation

Factors Contributing to Lower Mortality with Ticagrelor Compared with Clopidogrel in Patients Undergoing CABG Surgery

Presenter: Christoph Varenhorst

September 26, 2012

Presentation

Mortality Benefit with Prasugrel in the TRITON-TIMI 38 CABG Cohort

Presenter: 195949|Peter Smith

May 25, 2012

Presentation

Platelet Function Measurement-Based Strategy to Reduce Bleeding and Waiting Time in Clopidogrel-Treated Patients Undergoing CABG

Presenter: E. Mahla

March 13, 2012

Presentation

Estrategia basada en Medir la Función Plaquetaria para Reducir las Hemorragias en el Tiempo de Espera en Pacientes Tratados con Clopidogrel que se someten a un CABG

Presenter: E. Mahla

March 13, 2012

Advertisement

Intervention to Prevention

Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement

MINOCA: Causes and Investigation Algorithm

Case: Immediately after PCI and BAV the patient was given aspirin 250 mg iv and Plavix 300 mg

Prolonged DAPT should be Standard of Care Post PCI?

Predictors of Long-term Major CV Events and Death in Patients With Unprotected Left Main CAD

Risk of Adverse Cardiac and Bleeding Events Following Surgery in Patients With Stents

Factors Contributing to Lower Mortality with Ticagrelor Compared with Clopidogrel in Patients Undergoing CABG Surgery

Mortality Benefit with Prasugrel in the TRITON-TIMI 38 CABG Cohort

Platelet Function Measurement-Based Strategy to Reduce Bleeding and Waiting Time in Clopidogrel-Treated Patients Undergoing CABG

Estrategia basada en Medir la Función Plaquetaria para Reducir las Hemorragias en el Tiempo de Espera en Pacientes Tratados con Clopidogrel que se someten a un CABG

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content